Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Understanding high dividend yield stocks
18/05/2025
F&O Talk : Market mood lifts, Nifty to eye 24,740 as immediate target : Rahul Ghose
18/05/2025
Sebi mandates e-book mechanism for pvt debt securities above Rs 20 cr
18/05/2025
Q4 results this week : ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings
18/05/2025
IPO Calendar : Belrise Industries lead 4 IPOs that will rev up primary market next week
18/05/2025
FPIs pump Rs 18,620 cr in equities in May on global tailwinds, improving domestic fundamentals
18/05/2025
